[1]许斌,王子华,崔玉龙,等.腰痛宁胶囊治疗第三腰椎横突综合征临床研究*[J].陕西中医,2018,(11):1562-1564.
　Xu Bin,Wang Zihua,Cui Yulong,et al.Clinical efficacy of Yaotongning capsule in treating third lumbar transverse process syndrome[J].,2018,(11):1562-1564.
点击复制

腰痛宁胶囊治疗第三腰椎横突综合征临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2018年11期
页码:
1562-1564
栏目:
临床研究
出版日期:
2018-12-31

文章信息/Info

Title:
Clinical efficacy of Yaotongning capsule in treating third lumbar transverse process syndrome
文章编号:
10.3969/j.issn.1000-7369.2018.11.021
作者:
许斌1 ; 王子华2;  崔玉龙1;  刘红静3;  王晓东4
1.河南省胸科医院骨科（郑州 450000），2.河南中医药大学第一附属医院风湿科（郑州 450000）， 3.郑州大学附属肿瘤医院中西医外治中心（郑州 450000）， 4. 河南省商丘市睢县中医院风湿科（商丘 476000）
Author(s):
Xu Bin;  Wang Zihua;  Cui Yulong;  et al.
Department of Orthopedics, Henan Thoracic Hospital(Zhengzhou 450000)
关键词:
第三腰椎横突综合征 /中西医结合疗法阿司匹林/治疗应用@腰痛宁胶囊
Keywords:
3rd lumbarvertebraesyndrome/integratedChinese traditional and western medicine therapyAspirin/therapeutic uses @Yaotongning capsule
分类号:
R684
文献标志码:
A
摘要:
目的： 探讨腰痛宁胶囊治疗第三腰椎横突综合征的临床疗效。方法：选取第三腰椎横突综合征患者68例，随机数字表法分为对照组和观察组各34例。对照组给予口服阿司匹林加局部封闭治疗，观察组在对照组基础上给予腰痛宁胶囊治疗。比较两组治疗前后疼痛程度改善情况（VAS评分、PD值）及临床疗效。结果： 治疗后5、7、14　d，两组患者中医症状积分均明显下降，且观察组比对照组下降更明显（P<0.05）。治疗前两组VAS评分、PD值无明显差异（P>0.05）；治疗后两组VAS评分及PD值降低，且观察组明显优于对照组（P<0.05）；两组治疗后ODI均显著降低，JOA评分明显上升（P<0.05）；观察组治疗后明显优于对照组（P<0.05）；治疗后两组生活质量评分升高，且观察组优于对照组（P<0.05）。观察组显效率61.76%（21/34）、总有效率94.11%（32/34），均明显高于对照组，差异均具有统计学意义（P<0.05）。结论：腰痛宁胶囊可显著改善第三腰椎横突综合征临床症状，减轻患者腰椎疼痛程度。
Abstract:
Objective:To investigate the clinical efficacy of Yaotongning capsule in treating third lumbar transverse process syndrome. Methods: 68 cases of third lumbar transverse process syndrome treated in our department of orthopedics were selected as the research subjects. They were divided into control group and observation group by random number table grouping method, 34 cases in each group. The control group was given oral aspirin plus local blocking treatment, while the observation group was treated with Yaotongning capsule on the basis of the control group. The improvement of pain degree (VAS score, PD value) and clinical efficacy were compared between the two groups before and after treatment. Results:After treatment 5, 7, 14 d, two groups of patients with TCM symptom scores were significantly decreased, and the observation group decreased more significantly than the control group (P<0.05). There was no significant difference in VAS scores and PD values before treatment in the two groups (P>0.05); the VAS scores and PD values in the two groups were significantly lower (P<0.05); the VAS scores and PD values in the observation group were significantly lower than those in the control group (P<0.05); the ODI of the two groups decreased significantly and the JOA was significantly increased (P<0.05); the observation group was treated. After treatment, the effect was significantly better than that of the control group (P<0.05), the quality of life scores of the two groups increased significantly after treatment, and the observation group was significantly better than the control group (P<0.05). The effective rate of the observation group was 61.76% (21/34) and the total effective rate was 94.11% (32/34), which were significantly higher than that of the control group.The difference was statistically significant (P<0.05). Conclusion:Yaotongning capsule can improve the clinical symptoms of the third lumbar transverse process syndrome and reduce the degree of lumbar pain in the patients.

参考文献/References:

[1] 张永芳,徐江维.大剂量环磷酰胺治疗小儿难治性肾病综合征的临床疗效研究[J].陕西医学杂志,2018,47(1):105-107.
[2]连娜. 难治性肾病综合征应用低分子肝素与激素、环磷酰胺联合治疗的临床疗效分析[J]. 中国现代药物应用, 2016, 10(7):184-185.
[3]杨朔, 胡俊华, 王亚娟. 滋阴益肾活血方联合雷公藤多苷片治疗IgA肾病风湿内扰证的临床研究[J]. 浙江中医杂志, 2016, 51(1):11-13.
[4] 刘海燕, 刘镇江, 李芹. 综合方案治疗对肾病综合征患者血液高凝状态、血小板及肾功能的影响[J]. 血栓与止血学, 2016, 22(3):293-296.
[5] 中华中医药学会肾病分会. 原发性肾病综合征的诊断、辨证分型及疗效评定(试行方案)[J]. 上海中医药杂志, 2006, 40(10):51-52.
[6] 邓时素, 欧三桃. 甲泼尼龙联合他克莫司治疗老年原发性肾病综合征的临床观察[J]. 中国药房, 2016, 27(32):4528-4531.
[7] 赵庆瑞. 针对性治疗原发性肾病综合征并发急性肾功能衰竭的疗效及对患者生活质量的影响[J]. 临床合理用药杂志, 2016, 9(7):124-125.
[8]刘志远. 低分子肝素联合激素、环磷酰胺治疗难治性肾病综合征效果观察[J]. 中外医学研究, 2016, 14(31):38-39.
[9] 杨琛,蔡广研,陈仆,等.成人微小病变肾病综合征发生急性肾损伤的相关影响因素分析[J].中华肾病研究电子杂志,2018,7(1):28-33.
[10]胡浩强, 刘国辉. 肾病综合征并发心源性猝死的临床特点及相关危险因素分析[J]. 海南医学, 2016, 27(15):2516-2518.
[11]王倩涵, 史长松. 环磷酰胺与他克莫司治疗儿童激素耐药型肾病综合征的疗效对比[J]. 临床医药文献电子杂志, 2016, 3(31):6273-6274.
[12]张福港, 卞书森. 黄芪注射液配合西药治疗原发性肾病综合征临床研究[J]. 陕西中医, 2016, 37(8):1027-1028.
[13]王晶晶, 蒋媛, 储奕,等. 雷公藤多苷抑制二肽肽酶I活性及其调节机制的研究[J]. 中国免疫学杂志, 2017, 33(4):537-541.
[14]樊垒垒, 王幼平. 雷公藤多苷的抗炎作用研究进展[J]. 中国现代医生, 2016, 54(8):161-164.
[15]冯群, 孙蓉. 雷公藤多苷片抗炎作用及伴随肝毒性研究[J]. 中药新药与临床药理, 2014, 25(6):713-716.

备注/Memo

备注/Memo:
*河南省科技攻关项目（112102310277）
更新日期/Last Update: 2018-11-30